Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
31,523,534
-
Total 13F shares
-
522,673
-
Share change
-
+522,673
-
Total reported value
-
$7,830,000
-
Price per share
-
$14.97
-
Number of holders
-
13
-
Value change
-
+$7,829,989
-
Number of buys
-
13
Institutional Holders of ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA) as of Q4 2020
As of 31 Dec 2020,
ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
522,673 shares.
The largest 10 holders included
INGALLS & SNYDER LLC, JANE STREET GROUP, LLC, Gradient Capital Advisors, LLC, JPMORGAN CHASE & CO, Federation des caisses Desjardins du Quebec, Orion Portfolio Solutions, LLC, Hillsdale Investment Management Inc., BANK OF MONTREAL /CAN/, Rockefeller Capital Management L.P., and MORGAN STANLEY.
This page lists
14
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.